Upstate Active Clinical Trials

Study Title:

Allogeneic Peripheral Blood Stem Cell Transplant Utilizing Non-Myeloablative Conditioning Therapy. A Phase II Study.

What is the purpose of the study?

To provide non-myeloablative allogeneic transplantation for patients with matched related donor.

Upstate Institutional Review Board (IRB) Number:

323221

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Teresa C Gentile, MD, PhD

Who is eligible?

Diagnosis of non-hodgkin's lymphoma, chronic lymphocyte leukemia, myelodysplasia,acute lymphocytic leukemia, chronic myeloid leukemia in chronic phase or accelerated phase, myelofibrosis, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.

Pts 18-65 w/ hematologic malignancy who relapsed after prior auto-SCT, or pts age >50 w/ low grade relapsed non-hodgkins, relapsed CLL, myelodysplasia, AML in remission, ALL in remission, CML in chronic or accelerated phase, myelofibrosis, must have matched sibling donor

What is involved if I participate?

  • How long is the study?
    Inpatient stay approximately 21 days, followed for lifetime.
  • Is transportation provided or reimbursed?
    No
  • Is parking provided or reimbursed?
    No
  • What tests and procedures are involved?
    Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.

Where will the study take place?

SUNY Upstate Medical University,Syracuse, NY

Other Information:

Who can I contact for more information?

Name: Shramika Adhikary
Phone: 315-464-8271
Email: adhikars@upstate.edu

Return to Previous Page || Search Again